Search
  • Search

    Procurement of antiviral, Favipiravir 200mg tablets for Andes virus

    European Commission, DG HERA - European Health Emergency Preparedness and Response Authority

    Procurement of antiviral, Favipiravir 200mg tablets for Andes virus

    1. Supplier selection

      May 28, 12:00 AMMay 28, 2026 12:00 AM

    2. Result notice published

      Jun 26, 7:20 AMJune 26, 2026 7:20 AM

    Brief

    Belgium: Tenders/European Commission, DG HERA - European Health Emergency Preparedness and Response Authority/Procurement of antiviral, Favipiravir 200mg tablets for Andes virus

    Awarded

    The competition has ended and a winner has been selected.

    Qualification deadline
    Jun 25,Expired
    Award
    Price only
    Procedure
    Without prior noticeTwo stages
    Agreement
    Buying goodsover 2 months

    Brief

    The European Commission, DG HERA - European Health Emergency Preparedness and Response Authority, has awarded a contract to betapharm Arzneimittel GmbH for the urgent procurement of antiviral Favipiravir 200mg tablets for the Andes virus. This procurement, valued at 487,440 €, was initiated to provide immediate assistance to two Member States facing life-saving situations. The contract has a duration of 2 months.

    Medisinsk engroshandel

    Result

    TED
    • betapharm Arzneimittel GmbH
      Winner
    • Number of bids
      1
    • Contract value
      €487,440

    Custom Assessment Criteria

    • Get answers to your bid/no-bid criteria

      Set them up once and Cobrief answers them in every tender

    Will you bid?

    The agent sets up the bid and writes the first draft. Free for 14 days.

    Award Criteria

    • Description

      Please consult the procurement documents.

      Source

      No source found in the documents. Check the weight against the tender documents.

    Previous winners

    • Who are you up against?

      The suppliers who have won similar contracts at European Commission, DG HERA - European Health Emergency Preparedness and Response Authority

    From the notice

    • This urgent procurement was launched following a request for immediate assistance from 2 Member States to access the medical countermeasure, Favipiravir, to be administrated in active cases that are facing lifesaving situations.

    • Contact

      hera-joint-procurement-secretariat@ec.europa.eu
    • Type
      Result · Prequalification
    • Main code
      Medical equipments, pharmaceuticals and personal care products
      33000000
    • 33650000General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents33651000General anti-infectives for systemic use and vaccines33651400Antivirals for systemic use

    Similar active competitions

    • JZU Opsta Bolnica Ohrid

      medicines

      JZU Opsta Bolnica Ohrid needs medicines for a 1-year contract. The award criterion is the lowest price.

      Competition
      Nov 13, 2026(15 days)

    • Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

      Dekk og biltilbehør

      Capacity Reservation for Personal Protective Equipment Pilot

      The Health and Digital Executive Agency (HaDEA) in Belgium needs services for the reservation of manufacturing capacity and contractor-managed stockpiles of nitrile examination gloves (lot 1) and FFP2 respiratory masks (lot 2) for a duration of 3 years, with a maximum total value of 34,000,000 EUR. The purpose is to enhance the accessibility and availability of Medical Counter-Measures (MCMs) in the EU/EEA, with the contractor required to have manufacturing capacity within the EU/EEA. The contracting authority and/or the European Commission will have the right to purchase the stockpiled or manufactured MCMs for preparedness or crisis purposes. Each lot will be awarded to a maximum of three tenderers. Award criteria are Quality (60%) and Price (40%).

      Competition
      Dec 8, 2026(40 days)
      €34,000,000

    • Estado-Maior-General das Forças Armadas (EMGFA)

      2026005063/HFAR-Aquisição de Reagentes com Colocação de Equipamento Analítico em Regime de Cedência Gratuita - Realização de PCR para o Hospital das Forças Armadas - Polo de Lisboa

      O Estado-Maior-General das Forças Armadas (EMGFA) necessita da aquisição de reagentes com colocação de equipamento analítico em regime de cedência gratuita para a realização de PCR para o Hospital das Forças Armadas - Polo de Lisboa, na Grande Lisboa. O contrato terá uma duração de 3 anos e um valor máximo total estimado de 307.380 EUR. A avaliação das propostas será baseada no preço.

      Competition
      Nov 7, 2026(9 days)
      €307,380